BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Monday, May 13, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 1, 2012
View Archived Issues
GABAergic compound shows early promise in improving fragile X symptoms
Read More
Phase II trial begins for molecular imaging drug for prostate cancer
Read More
Amakem begins phase IIa AMA-0076 trial
Read More
University of Chicago designs novel anti-staphylococcal agents
Read More
Research at the University of Pennsylvania yields new cancer biotherapeutics
Read More
Novel AMPK activators disclosed in GSK patent
Read More
Seebri Breezhaler approved for COPD maintenance treatment in Japan
Read More
New York University presents new PGRN variants for inflammation
Read More
Pfizer obtains approval for Tygacil in Japan
Read More
Further clinical data reported on cancer vaccine MGN-1601 at ESMO
Read More
Neuralstem cleared to study NSI-566 in China
Read More
Novel BACE1 inhibitors created at Janssen Pharmaceutica
Read More
Phase I data on veliparib in patients with brain metastases reported
Read More
Roche presents new antidiabetic compounds
Read More
Dainippon Sumitomo Pharma obtains approval for Aimix combination tablets
Read More
Ariad completes rolling NDA submission for ponatinib
Read More
Novartis obtains Japanese approval for tobramycin
Read More
FDA expands approval of Venofer to pediatric patients
Read More
Phase III trial of OncoGenex' lead candidate commences in advanced NSCLC
Read More
Stem cell gene therapy shows promise in mucopolysaccharidosis IIIA model
Read More
Vital Therapies closes first stage of financing to fund phase III program for Elad
Read More
Osiris Therapeutics regains rights to Prochymal and Chondrogen
Read More
StemCells gives update on phase I/II chronic spinal cord injury study
Read More
Teva acquires Huntexil development program rights from NeuroSearch
Read More
Zosyn receives new indication approvals in Japan
Read More
Lotriga approved in Japan for the treatment of hyperlipidemia
Read More